Detection of CD133-marked cancer stem cells by surface plasmon resonance: Its application in leukemia patients

Here, we reported the development of a label-free and real-time surface plasmon resonance (SPR) based biosensor for cancer stem cells (CSCs) detection using cell surface biomarker; CD133. The fabricated biosensor was used for detection of this marker in some acute myeloid leukemia (AML) patients and...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. General subjects Vol. 1863; no. 10; pp. 1575 - 1582
Main Authors Fathi, Farzaneh, Rahbarghazi, Reza, Movassaghpour, Ali Akbar, Rashidi, Mohammad-Reza
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.10.2019
Subjects
AC133 Antigen - analysis
Acute myeloid leukemia
Adult
antibodies
biomarkers
biosensors
bone marrow
Cancer stem cells
CD133
Female
Flow cytometry
gold
Humans
Leukemia, Myeloid, Acute - immunology
Leukemia, Myeloid, Acute - pathology
Male
myeloid leukemia
Neoplastic Stem Cells - cytology
Neoplastic Stem Cells - immunology
patients
SPR
stem cells
Surface Plasmon Resonance
Flow cytometry
SPR
Cancer stem cells
Acute myeloid leukemia
CD133
Online AccessGet full text

Cover

Abstract Here, we reported the development of a label-free and real-time surface plasmon resonance (SPR) based biosensor for cancer stem cells (CSCs) detection using cell surface biomarker; CD133. The fabricated biosensor was used for detection of this marker in some acute myeloid leukemia (AML) patients and the results were compared with those obtained from flow cytometry (FC) method. CD133 antibody was immobilized on the gold chip surface via EDC/NHS coupling method and binding of the candidate cells to the modified gold sensor surface was monitored after isolation of mononuclear cells from bone marrow of the patients. The method was validated in terms of various parameters such as CD133- antibody concentration and cell density. The CD133-marked cells were investigated in seven AML patients. All SPR results were compared with those obtained from FC method. A very good correlation (R2 = 0.96) was obtained between SPR and FC responses related to CD133-marked cells densities. In conclusion, in this study, a label-free and real-time SPR cytometry method was developed to detect CD133 and it was successfully applied to follow this cancer stem cell biomarker in AML patients. [Display omitted] •SPR-based method was developed for detection of CD133+ cancer stem cells in patients with AML.•SPR was validated by using CD133 antibody concentrations and cell density.•A strong correlation was obtained between SPR and flow cytometry responses.
AbstractList Here, we reported the development of a label-free and real-time surface plasmon resonance (SPR) based biosensor for cancer stem cells (CSCs) detection using cell surface biomarker; CD133. The fabricated biosensor was used for detection of this marker in some acute myeloid leukemia (AML) patients and the results were compared with those obtained from flow cytometry (FC) method. CD133 antibody was immobilized on the gold chip surface via EDC/NHS coupling method and binding of the candidate cells to the modified gold sensor surface was monitored after isolation of mononuclear cells from bone marrow of the patients. The method was validated in terms of various parameters such as CD133- antibody concentration and cell density. The CD133-marked cells were investigated in seven AML patients. All SPR results were compared with those obtained from FC method. A very good correlation (R2 = 0.96) was obtained between SPR and FC responses related to CD133-marked cells densities. In conclusion, in this study, a label-free and real-time SPR cytometry method was developed to detect CD133 and it was successfully applied to follow this cancer stem cell biomarker in AML patients.
Here, we reported the development of a label-free and real-time surface plasmon resonance (SPR) based biosensor for cancer stem cells (CSCs) detection using cell surface biomarker; CD133. The fabricated biosensor was used for detection of this marker in some acute myeloid leukemia (AML) patients and the results were compared with those obtained from flow cytometry (FC) method. CD133 antibody was immobilized on the gold chip surface via EDC/NHS coupling method and binding of the candidate cells to the modified gold sensor surface was monitored after isolation of mononuclear cells from bone marrow of the patients. The method was validated in terms of various parameters such as CD133- antibody concentration and cell density. The CD133-marked cells were investigated in seven AML patients. All SPR results were compared with those obtained from FC method. A very good correlation (R2 = 0.96) was obtained between SPR and FC responses related to CD133-marked cells densities. In conclusion, in this study, a label-free and real-time SPR cytometry method was developed to detect CD133 and it was successfully applied to follow this cancer stem cell biomarker in AML patients. [Display omitted] •SPR-based method was developed for detection of CD133+ cancer stem cells in patients with AML.•SPR was validated by using CD133 antibody concentrations and cell density.•A strong correlation was obtained between SPR and flow cytometry responses.
Here, we reported the development of a label-free and real-time surface plasmon resonance (SPR) based biosensor for cancer stem cells (CSCs) detection using cell surface biomarker; CD133. The fabricated biosensor was used for detection of this marker in some acute myeloid leukemia (AML) patients and the results were compared with those obtained from flow cytometry (FC) method. CD133 antibody was immobilized on the gold chip surface via EDC/NHS coupling method and binding of the candidate cells to the modified gold sensor surface was monitored after isolation of mononuclear cells from bone marrow of the patients. The method was validated in terms of various parameters such as CD133- antibody concentration and cell density. The CD133-marked cells were investigated in seven AML patients. All SPR results were compared with those obtained from FC method. A very good correlation (R  = 0.96) was obtained between SPR and FC responses related to CD133-marked cells densities. In conclusion, in this study, a label-free and real-time SPR cytometry method was developed to detect CD133 and it was successfully applied to follow this cancer stem cell biomarker in AML patients.
Here, we reported the development of a label-free and real-time surface plasmon resonance (SPR) based biosensor for cancer stem cells (CSCs) detection using cell surface biomarker; CD133. The fabricated biosensor was used for detection of this marker in some acute myeloid leukemia (AML) patients and the results were compared with those obtained from flow cytometry (FC) method. CD133 antibody was immobilized on the gold chip surface via EDC/NHS coupling method and binding of the candidate cells to the modified gold sensor surface was monitored after isolation of mononuclear cells from bone marrow of the patients. The method was validated in terms of various parameters such as CD133- antibody concentration and cell density. The CD133-marked cells were investigated in seven AML patients. All SPR results were compared with those obtained from FC method. A very good correlation (R2 = 0.96) was obtained between SPR and FC responses related to CD133-marked cells densities. In conclusion, in this study, a label-free and real-time SPR cytometry method was developed to detect CD133 and it was successfully applied to follow this cancer stem cell biomarker in AML patients.Here, we reported the development of a label-free and real-time surface plasmon resonance (SPR) based biosensor for cancer stem cells (CSCs) detection using cell surface biomarker; CD133. The fabricated biosensor was used for detection of this marker in some acute myeloid leukemia (AML) patients and the results were compared with those obtained from flow cytometry (FC) method. CD133 antibody was immobilized on the gold chip surface via EDC/NHS coupling method and binding of the candidate cells to the modified gold sensor surface was monitored after isolation of mononuclear cells from bone marrow of the patients. The method was validated in terms of various parameters such as CD133- antibody concentration and cell density. The CD133-marked cells were investigated in seven AML patients. All SPR results were compared with those obtained from FC method. A very good correlation (R2 = 0.96) was obtained between SPR and FC responses related to CD133-marked cells densities. In conclusion, in this study, a label-free and real-time SPR cytometry method was developed to detect CD133 and it was successfully applied to follow this cancer stem cell biomarker in AML patients.
Author Movassaghpour, Ali Akbar
Rashidi, Mohammad-Reza
Fathi, Farzaneh
Rahbarghazi, Reza
Author_xml – sequence: 1
  givenname: Farzaneh
  surname: Fathi
  fullname: Fathi, Farzaneh
  organization: Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
– sequence: 2
  givenname: Reza
  surname: Rahbarghazi
  fullname: Rahbarghazi, Reza
  organization: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
– sequence: 3
  givenname: Ali Akbar
  surname: Movassaghpour
  fullname: Movassaghpour, Ali Akbar
  organization: Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
– sequence: 4
  givenname: Mohammad-Reza
  surname: Rashidi
  fullname: Rashidi, Mohammad-Reza
  email: rashidi@tbzmed.ac.ir
  organization: Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31228554$$D View this record in MEDLINE/PubMed
BookMark eNqNkUtv1TAQhS1URG8L_wAhL9kk2PHjJl0goVselSqxgbU1ccbIt4kTbAep_x6nt92wAGYz0ug7R5pzLshZmAMS8pqzmjOu3x3rvocfGOqG8a5mumase0Z2vN03VcuYPiM7JpisJNfqnFykdGRlVKdekHPBm6ZVSu5IuMaMNvs50NnRwzUXopog3uFALQSLkaaME7U4jon29zSt0YFFuoyQpiKKmOawgVf0JicKyzJ6Cw9-PtAR1zucPNClnDDk9JI8dzAmfPW4L8n3Tx-_Hb5Ut18_3xw-3FZWdCpXwLR2DBrhQCiJSnM7uE4CuE5j0znQ-wacRrbXreaKCdnDoFqF2u6hbUFckrcn3yXOP1dM2Uw-bU9AwHlNpryvW9VpJv8DlUpLrroNffOIrv2Eg1miL1ndm6c4C3B1AmycU4rojPX5IY0cwY-GM7N1Z47m1J3ZujNMm9JdEcs_xE_-_5C9P8mw5PnLYzTJlqwtDj6WZs0w-78b_AYZ2bSQ
CitedBy_id crossref_primary_10_1007_s12015_020_10114_6
crossref_primary_10_1016_j_ejps_2020_105362
crossref_primary_10_1016_j_trac_2024_118063
crossref_primary_10_1149_2162_8777_abf757
crossref_primary_10_1016_j_snb_2023_134490
crossref_primary_10_1016_j_talanta_2020_120782
crossref_primary_10_1016_j_actbio_2022_03_036
crossref_primary_10_1007_s00277_024_05777_x
crossref_primary_10_3390_s21093254
crossref_primary_10_1016_j_bios_2021_113767
crossref_primary_10_1016_j_biosx_2022_100245
crossref_primary_10_1016_j_colsurfa_2020_125842
crossref_primary_10_1016_j_bios_2020_112511
crossref_primary_10_1016_j_bios_2020_112599
crossref_primary_10_1016_j_cis_2022_102727
crossref_primary_10_1007_s13273_022_00287_1
crossref_primary_10_34172_jcvtr_2021_27
crossref_primary_10_1016_j_microc_2024_110141
crossref_primary_10_1016_j_bios_2025_117308
crossref_primary_10_1016_j_talanta_2024_126852
crossref_primary_10_1016_j_talanta_2022_123828
crossref_primary_10_1016_j_ab_2021_114544
crossref_primary_10_18632_oncotarget_27870
crossref_primary_10_1016_j_molstruc_2022_134509
crossref_primary_10_1007_s10867_021_09599_0
crossref_primary_10_3390_bios13030396
crossref_primary_10_3390_mi11040356
crossref_primary_10_1055_a_1533_2941
crossref_primary_10_1016_j_jddst_2022_103377
crossref_primary_10_1007_s11468_022_01615_w
Cites_doi 10.1021/acssensors.8b00523
10.1016/j.molmed.2008.08.003
10.15171/bi.2017.12
10.1016/j.bios.2013.08.027
10.1016/j.ab.2014.11.001
10.1038/s41598-017-16940-y
10.1016/j.bbagen.2011.10.008
10.15171/bi.2019.10
10.1016/j.ab.2015.06.018
10.1002/cbf.3251
10.1182/blood.V90.12.5013
10.1016/j.bios.2017.05.018
10.1016/j.ijpharm.2011.06.001
10.1016/j.bios.2017.08.042
10.1016/j.biocel.2004.08.010
10.1182/blood.V94.2.832
10.1007/s00604-011-0656-6
10.1016/j.jconrel.2018.08.043
10.1016/j.bios.2011.04.016
10.1182/blood.V90.12.5002
10.1016/j.talanta.2018.09.023
10.1016/j.bbagen.2018.03.002
10.3390/bios8040102
10.1016/j.bios.2017.10.028
10.1016/j.tcb.2005.07.004
10.1038/nm0797-730
10.15171/apb.2017.023
10.1016/j.ijleo.2017.05.001
10.3390/s140304948
10.1016/j.bios.2015.11.020
10.1021/ac5023056
10.1016/S0022-1759(97)00092-6
10.1373/clinchem.2016.271049
10.1016/B978-0-323-06398-2.00014-X
ContentType Journal Article
Copyright 2019
Copyright © 2019. Published by Elsevier B.V.
Copyright_xml – notice: 2019
– notice: Copyright © 2019. Published by Elsevier B.V.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1016/j.bbagen.2019.06.009
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
EndPage 1582
ExternalDocumentID 31228554
10_1016_j_bbagen_2019_06_009
S0304416519301588
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFKBS
7S9
L.6
ID FETCH-LOGICAL-c395t-a066f0a23fa354e561cdf94aaf96e29fa672af6e0768615034bad585e6c7a88a3
IEDL.DBID .~1
ISSN 0304-4165
1872-8006
IngestDate Fri Jul 11 10:51:54 EDT 2025
Tue Aug 05 11:23:42 EDT 2025
Thu Apr 03 06:57:47 EDT 2025
Thu Apr 24 22:58:40 EDT 2025
Tue Jul 01 00:22:12 EDT 2025
Fri Feb 23 02:34:15 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Flow cytometry
SPR
Cancer stem cells
Acute myeloid leukemia
CD133
Language English
License Copyright © 2019. Published by Elsevier B.V.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c395t-a066f0a23fa354e561cdf94aaf96e29fa672af6e0768615034bad585e6c7a88a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 31228554
PQID 2245641594
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2286859604
proquest_miscellaneous_2245641594
pubmed_primary_31228554
crossref_citationtrail_10_1016_j_bbagen_2019_06_009
crossref_primary_10_1016_j_bbagen_2019_06_009
elsevier_sciencedirect_doi_10_1016_j_bbagen_2019_06_009
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2019
2019-10-00
20191001
PublicationDateYYYYMMDD 2019-10-01
PublicationDate_xml – month: 10
  year: 2019
  text: October 2019
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta. General subjects
PublicationTitleAlternate Biochim Biophys Acta Gen Subj
PublicationYear 2019
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Yanase, Hiragun, Ishii, Kawaguchi, Yanase, Kawai, Sakamoto, Hide (bb0100) 2014; 14
Fathi, Rashidi, Omidi (bb0060) 2018; 192
Soler, Li, John-Herpin, Schmidt, Coukos, Altug (bb0105) 2018; 3
Quinn, O’Kennedy, Smyth, Moulds, Frame (bb0175) 1997; 206
Stojanović, Schasfoort, Terstappen (bb0135) 2014; 52
Akbarzadeh, Movassaghpour, Ghanbari, Kheirandish, Maroufi, Rahbarghazi, Nouri, Samadi (bb0020) 2017; 7
Bonnet, Dick (bb0025) 1997; 3
Stern, Pauly, Zydek, Müller, Avondet, Worbs, Lisdat, Dorner, Dorner (bb0090) 2016; 78
Bühring, Seiffert, Marxer, Faul, Kanz, Brugger (bb0045) 1999; 94
Klonisch, Wiechec, Hombach-Klonisch, Ande, Wesselborg, Schulze-Osthoff, Los (bb0015) 2008; 14
Fathi, Rezabakhsh, Rahbarghazi, Rashidi (bb0155) 2017; 96
Stojanović, van der Velden, Mulder, Schasfoort, Terstappen (bb0150) 2015; 485
J. Irudayaraj, C. Yu, Multiplex Detection of Cell Surface Markers Using Plasmonic Sensors J. Irudayaraj, C. Yu, H. Nakshatri, S. Leavesley, B. Rajwa, P. Robinson
Cortès, Villiers, Colpo, Couderc, Brakha, Rossi, Marche, Villiers (bb0130) 2011; 26
Lago, Nadai, Rossetto, Richter (bb0065) 2018; 1862
Maedel, Rodak (bb0195) 2002
Rahman, Anower, Rahman, Hasan, Hossain, Haque (bb0080) 2017; 140
Miraglia, Godfrey, Yin, Atkins, Warnke, Holden, Bray, Waller, Buck (bb0035) 1997; 90
Shmelkov, Clair, Lyden, Rafii (bb0040) 2005; 37
Zhao, Duan, Yuan, Quan, Yang, Xi (bb0055) 2014; 9
Schasfoort, Abali, Stojanovic, Vidarsson, Terstappen (bb0125) 2018; 8
Cascavilla, Musto, D'Arena, Melillo, Carella, Petrilli, Sanpaolo, Carotenuto (bb0180) 1998; 83
Wang, Dick (bb0005) 2005; 15
Gorodkiewicz, Ostrowska, Sankiewicz (bb0115) 2011; 175
Rezabakhsh, Nabat, Yousefi, Montazersaheb, Cheraghi, Mehdizadeh, Fathi, Movassaghpour, Maleki-Dizaji, Rahbarghazi (bb0160) 2017; 35
Gool, Stojanovic, Schasfoort, Sturk, Van Leeuwen, Nieuwland, Terstappen, Coumans (bb0185) 2017; 63
Caperna, Sitapati, Tiu (bb0190) 2012; 158
Bourseau-Guilmain, Béjaud, Griveau, Lautram, Hindré, Weyland, Benoit, Garcion (bb0050) 2012; 423
XIE, WANG, CHENG, ZHANG, WANG, FANG (bb0145) 2011; 24
Zhu, Wang, Cui, Liu, Bu, Ma, Wang, Gong, Lausted, Hood (bb0120) 2014; 86
Diao, Tang, Ding, Li, Cheng, Mo, Yan, Ma, Yan (bb0085) 2018; 100
Fathi, Rahbarghazi, Rashidi (bb0170) 2018; 101
Fathi, Rashidi, Amjadi, Jalili (bb0095) 2018; 9
Dianat-Moghadam, Heydarifard, Jahanban-Esfahlan, Panahi, Hamishehkar, Pouremamali, Rahbarghazi, Nouri (bb0010) 2018; 288
Tyagi, Perez, Nand, Zhiqiang, Wang, Na, Zhu (bb0140) 2015; 471
Yin, Miraglia, Zanjani, Almeida-Porada, Ogawa, Leary, Olweus, Kearney, Buck (bb0030) 1997; 90
Sharifi, Dolatabadi, Fathi, Zakariazadeh, Barzegar, Rashidi, Tajalli, Rashidi (bb0075) 2017; 7
Shanehbandi, Majidi, Kazemi, Baradaran, Aghebati-Maleki, Fathi, Dolatabadi (bb0165) 2017; 7
Rajabi, Struble, Zhou, Karnaukhova (bb0070) 2012; 1820
Rezabakhsh (10.1016/j.bbagen.2019.06.009_bb0160) 2017; 35
Akbarzadeh (10.1016/j.bbagen.2019.06.009_bb0020) 2017; 7
Schasfoort (10.1016/j.bbagen.2019.06.009_bb0125) 2018; 8
Klonisch (10.1016/j.bbagen.2019.06.009_bb0015) 2008; 14
Yanase (10.1016/j.bbagen.2019.06.009_bb0100) 2014; 14
Miraglia (10.1016/j.bbagen.2019.06.009_bb0035) 1997; 90
Fathi (10.1016/j.bbagen.2019.06.009_bb0095) 2018; 9
Yin (10.1016/j.bbagen.2019.06.009_bb0030) 1997; 90
Wang (10.1016/j.bbagen.2019.06.009_bb0005) 2005; 15
10.1016/j.bbagen.2019.06.009_bb0110
XIE (10.1016/j.bbagen.2019.06.009_bb0145) 2011; 24
Quinn (10.1016/j.bbagen.2019.06.009_bb0175) 1997; 206
Cascavilla (10.1016/j.bbagen.2019.06.009_bb0180) 1998; 83
Dianat-Moghadam (10.1016/j.bbagen.2019.06.009_bb0010) 2018; 288
Diao (10.1016/j.bbagen.2019.06.009_bb0085) 2018; 100
Stojanović (10.1016/j.bbagen.2019.06.009_bb0150) 2015; 485
Stojanović (10.1016/j.bbagen.2019.06.009_bb0135) 2014; 52
Fathi (10.1016/j.bbagen.2019.06.009_bb0170) 2018; 101
Gorodkiewicz (10.1016/j.bbagen.2019.06.009_bb0115) 2011; 175
Stern (10.1016/j.bbagen.2019.06.009_bb0090) 2016; 78
Fathi (10.1016/j.bbagen.2019.06.009_bb0060) 2018; 192
Soler (10.1016/j.bbagen.2019.06.009_bb0105) 2018; 3
Maedel (10.1016/j.bbagen.2019.06.009_bb0195) 2002
Lago (10.1016/j.bbagen.2019.06.009_bb0065) 2018; 1862
Zhu (10.1016/j.bbagen.2019.06.009_bb0120) 2014; 86
Bourseau-Guilmain (10.1016/j.bbagen.2019.06.009_bb0050) 2012; 423
Cortès (10.1016/j.bbagen.2019.06.009_bb0130) 2011; 26
Shanehbandi (10.1016/j.bbagen.2019.06.009_bb0165) 2017; 7
Bühring (10.1016/j.bbagen.2019.06.009_bb0045) 1999; 94
Shmelkov (10.1016/j.bbagen.2019.06.009_bb0040) 2005; 37
Rajabi (10.1016/j.bbagen.2019.06.009_bb0070) 2012; 1820
Rahman (10.1016/j.bbagen.2019.06.009_bb0080) 2017; 140
Gool (10.1016/j.bbagen.2019.06.009_bb0185) 2017; 63
Bonnet (10.1016/j.bbagen.2019.06.009_bb0025) 1997; 3
Zhao (10.1016/j.bbagen.2019.06.009_bb0055) 2014; 9
Fathi (10.1016/j.bbagen.2019.06.009_bb0155) 2017; 96
Caperna (10.1016/j.bbagen.2019.06.009_bb0190) 2012; 158
Tyagi (10.1016/j.bbagen.2019.06.009_bb0140) 2015; 471
Sharifi (10.1016/j.bbagen.2019.06.009_bb0075) 2017; 7
References_xml – volume: 1820
  start-page: 56
  year: 2012
  end-page: 63
  ident: bb0070
  article-title: Potentiation of C1-esterase inhibitor by heparin and interactions with C1s protease as assessed by surface plasmon resonance
  publication-title: Biochimica et Biophysica Acta (BBA)-General Subjects
– volume: 100
  start-page: 228
  year: 2018
  end-page: 234
  ident: bb0085
  article-title: Highly sensitive surface plasmon resonance biosensor for the detection of HIV-related DNA based on dynamic and structural DNA nanodevices
  publication-title: Biosens. Bioelectron.
– volume: 96
  start-page: 358
  year: 2017
  end-page: 366
  ident: bb0155
  article-title: Early-stage detection of VE-cadherin during endothelial differentiation of human mesenchymal stem cells using SPR biosensor
  publication-title: Biosens. Bioelectron.
– volume: 206
  start-page: 87
  year: 1997
  end-page: 96
  ident: bb0175
  article-title: Detection of blood group antigens utilising immobilised antibodies and surface plasmon resonance
  publication-title: J. Immunol. Methods
– volume: 52
  start-page: 36
  year: 2014
  end-page: 43
  ident: bb0135
  article-title: Analysis of cell surface antigens by surface plasmon resonance imaging
  publication-title: Biosens. Bioelectron.
– volume: 158
  start-page: 376
  year: 2012
  ident: bb0190
  article-title: Acquired immunodeficiency syndrome and human immunodeficiency virus infection
  publication-title: Medical Secrets
– volume: 192
  start-page: 118
  year: 2018
  end-page: 127
  ident: bb0060
  article-title: Ultra-sensitive detection by metal nanoparticles-mediated enhanced SPR biosensors
  publication-title: Talanta
– volume: 140
  start-page: 989
  year: 2017
  end-page: 997
  ident: bb0080
  article-title: Modeling of a highly sensitive MoS2-graphene hybrid based fiber optic SPR biosensor for sensing DNA hybridization
  publication-title: Optik-International Journal for Light and Electron Optics
– volume: 485
  start-page: 112
  year: 2015
  end-page: 118
  ident: bb0150
  article-title: Quantification of antibody production of individual hybridoma cells by surface plasmon resonance imaging
  publication-title: Anal. Biochem.
– volume: 1862
  start-page: 1276
  year: 2018
  end-page: 1282
  ident: bb0065
  article-title: Surface Plasmon resonance kinetic analysis of the interaction between G-quadruplex nucleic acids and an anti-G-quadruplex monoclonal antibody
  publication-title: Biochimica et Biophysica Acta (BBA)-General Subjects
– volume: 7
  start-page: 91
  year: 2017
  ident: bb0075
  article-title: Surface plasmon resonance and molecular docking studies of bovine serum albumin interaction with neomycin: kinetic and thermodynamic analysis
  publication-title: BioImpacts: BI
– volume: 175
  start-page: 177
  year: 2011
  ident: bb0115
  article-title: SPR imaging biosensor for the 20S proteasome: sensor development and application to measurement of proteasomes in human blood plasma
  publication-title: Microchim. Acta
– volume: 26
  start-page: 4162
  year: 2011
  end-page: 4168
  ident: bb0130
  article-title: Biosensor for direct cell detection, quantification and analysis
  publication-title: Biosens. Bioelectron.
– volume: 83
  start-page: 392
  year: 1998
  end-page: 397
  ident: bb0180
  article-title: CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype
  publication-title: Haematologica
– start-page: 171
  year: 2002
  end-page: 183
  ident: bb0195
  article-title: Examination of Peripheral Blood Smears, Rodak BF,(Edi). Hematology: Clinical Principles and Applications
– volume: 8
  start-page: 102
  year: 2018
  ident: bb0125
  article-title: Trends in SPR cytometry: advances in label-free detection of cell parameters
  publication-title: Biosensors
– volume: 90
  start-page: 5013
  year: 1997
  end-page: 5021
  ident: bb0035
  article-title: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning
  publication-title: Blood
– volume: 288
  start-page: 62
  year: 2018
  end-page: 83
  ident: bb0010
  article-title: Cancer stem cells-emanated therapy resistance: implications for liposomal drug delivery systems
  publication-title: J. Control Release
– volume: 3
  start-page: 2286
  year: 2018
  end-page: 2295
  ident: bb0105
  article-title: Two-dimensional label-free affinity analysis of tumor-specific CD8 T cells with a biomimetic plasmonic sensor
  publication-title: ACS Sensors
– reference: J. Irudayaraj, C. Yu, Multiplex Detection of Cell Surface Markers Using Plasmonic Sensors J. Irudayaraj, C. Yu, H. Nakshatri, S. Leavesley, B. Rajwa, P. Robinson
– volume: 90
  start-page: 5002
  year: 1997
  end-page: 5012
  ident: bb0030
  article-title: AC133, a novel marker for human hematopoietic stem and progenitor cells
  publication-title: Blood
– volume: 94
  start-page: 832
  year: 1999
  end-page: 833
  ident: bb0045
  article-title: AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors
  publication-title: Blood
– volume: 9
  start-page: 75
  year: 2018
  end-page: 84
  ident: bb0095
  article-title: SPR signals enhancement by gold nanorods for cell surface marker detection
  publication-title: BioImpacts
– volume: 14
  start-page: 450
  year: 2008
  end-page: 460
  ident: bb0015
  article-title: Cancer stem cell markers in common cancers–therapeutic implications
  publication-title: Trends Mol. Med.
– volume: 9
  start-page: 1097
  year: 2014
  ident: bb0055
  article-title: A reusable localized surface plasmon resonance biosensor for quantitative detection of serum squamous cell carcinoma antigen in cervical cancer patients based on silver nanoparticles array
  publication-title: Int. J. Nanomedicine
– volume: 24
  start-page: 4
  year: 2011
  ident: bb0145
  article-title: Application of SPR biosensors in the detection of acute myeloid leukemia-associated antigen CD33
  publication-title: Chinese J. Sensors and Actuators
– volume: 101
  start-page: 188
  year: 2018
  end-page: 198
  ident: bb0170
  article-title: Label-free biosensors in the field of stem cell biology
  publication-title: Biosens. Bioelectron.
– volume: 471
  start-page: 29
  year: 2015
  end-page: 37
  ident: bb0140
  article-title: Detection of embryonic stem cell lysate biomarkers by surface plasmon resonance with reduced nonspecific adsorption
  publication-title: Anal. Biochem.
– volume: 7
  year: 2017
  ident: bb0020
  article-title: The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells
  publication-title: Sci. Rep.
– volume: 423
  start-page: 93
  year: 2012
  end-page: 101
  ident: bb0050
  article-title: Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133
  publication-title: Int. J. Pharm.
– volume: 35
  start-page: 83
  year: 2017
  end-page: 97
  ident: bb0160
  article-title: Endothelial cells’ biophysical, biochemical, and chromosomal aberrancies in high-glucose condition within the diabetic range
  publication-title: Cell Biochem. Funct.
– volume: 3
  start-page: 730
  year: 1997
  ident: bb0025
  article-title: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
  publication-title: Nat. Med.
– volume: 86
  start-page: 8857
  year: 2014
  end-page: 8864
  ident: bb0120
  article-title: Label-free quantitative detection of tumor-derived exosomes through surface plasmon resonance imaging
  publication-title: Anal. Chem.
– volume: 37
  start-page: 715
  year: 2005
  end-page: 719
  ident: bb0040
  article-title: AC133/CD133/Prominin-1
  publication-title: Int. J. Biochem. Cell Biol.
– volume: 78
  start-page: 111
  year: 2016
  end-page: 117
  ident: bb0090
  article-title: Simultaneous differentiation and quantification of ricin and agglutinin by an antibody-sandwich surface plasmon resonance sensor
  publication-title: Biosens. Bioelectron.
– volume: 14
  start-page: 4948
  year: 2014
  end-page: 4959
  ident: bb0100
  article-title: Surface plasmon resonance for cell-based clinical diagnosis
  publication-title: Sensors
– volume: 7
  start-page: 189
  year: 2017
  ident: bb0165
  article-title: Immuno-biosensor for detection of CD20-positive cells using surface Plasmon resonance
  publication-title: Adv. Pharm. Bull.
– volume: 15
  start-page: 494
  year: 2005
  end-page: 501
  ident: bb0005
  article-title: Cancer stem cells: lessons from leukemia
  publication-title: Trends Cell Biol.
– volume: 63
  start-page: 1633
  year: 2017
  end-page: 1641
  ident: bb0185
  article-title: Surface plasmon resonance is an analytically sensitive method for antigen profiling of extracellular vesicles
  publication-title: Clin. Chem.
– volume: 3
  start-page: 2286
  issue: 11
  year: 2018
  ident: 10.1016/j.bbagen.2019.06.009_bb0105
  article-title: Two-dimensional label-free affinity analysis of tumor-specific CD8 T cells with a biomimetic plasmonic sensor
  publication-title: ACS Sensors
  doi: 10.1021/acssensors.8b00523
– volume: 14
  start-page: 450
  year: 2008
  ident: 10.1016/j.bbagen.2019.06.009_bb0015
  article-title: Cancer stem cell markers in common cancers–therapeutic implications
  publication-title: Trends Mol. Med.
  doi: 10.1016/j.molmed.2008.08.003
– volume: 7
  start-page: 91
  year: 2017
  ident: 10.1016/j.bbagen.2019.06.009_bb0075
  article-title: Surface plasmon resonance and molecular docking studies of bovine serum albumin interaction with neomycin: kinetic and thermodynamic analysis
  publication-title: BioImpacts: BI
  doi: 10.15171/bi.2017.12
– volume: 52
  start-page: 36
  year: 2014
  ident: 10.1016/j.bbagen.2019.06.009_bb0135
  article-title: Analysis of cell surface antigens by surface plasmon resonance imaging
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2013.08.027
– volume: 471
  start-page: 29
  year: 2015
  ident: 10.1016/j.bbagen.2019.06.009_bb0140
  article-title: Detection of embryonic stem cell lysate biomarkers by surface plasmon resonance with reduced nonspecific adsorption
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2014.11.001
– volume: 7
  year: 2017
  ident: 10.1016/j.bbagen.2019.06.009_bb0020
  article-title: The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-16940-y
– volume: 1820
  start-page: 56
  year: 2012
  ident: 10.1016/j.bbagen.2019.06.009_bb0070
  article-title: Potentiation of C1-esterase inhibitor by heparin and interactions with C1s protease as assessed by surface plasmon resonance
  publication-title: Biochimica et Biophysica Acta (BBA)-General Subjects
  doi: 10.1016/j.bbagen.2011.10.008
– volume: 9
  start-page: 75
  year: 2018
  ident: 10.1016/j.bbagen.2019.06.009_bb0095
  article-title: SPR signals enhancement by gold nanorods for cell surface marker detection
  publication-title: BioImpacts
  doi: 10.15171/bi.2019.10
– volume: 485
  start-page: 112
  year: 2015
  ident: 10.1016/j.bbagen.2019.06.009_bb0150
  article-title: Quantification of antibody production of individual hybridoma cells by surface plasmon resonance imaging
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2015.06.018
– volume: 83
  start-page: 392
  year: 1998
  ident: 10.1016/j.bbagen.2019.06.009_bb0180
  article-title: CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype
  publication-title: Haematologica
– volume: 35
  start-page: 83
  year: 2017
  ident: 10.1016/j.bbagen.2019.06.009_bb0160
  article-title: Endothelial cells’ biophysical, biochemical, and chromosomal aberrancies in high-glucose condition within the diabetic range
  publication-title: Cell Biochem. Funct.
  doi: 10.1002/cbf.3251
– volume: 90
  start-page: 5013
  year: 1997
  ident: 10.1016/j.bbagen.2019.06.009_bb0035
  article-title: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning
  publication-title: Blood
  doi: 10.1182/blood.V90.12.5013
– volume: 96
  start-page: 358
  year: 2017
  ident: 10.1016/j.bbagen.2019.06.009_bb0155
  article-title: Early-stage detection of VE-cadherin during endothelial differentiation of human mesenchymal stem cells using SPR biosensor
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2017.05.018
– volume: 423
  start-page: 93
  year: 2012
  ident: 10.1016/j.bbagen.2019.06.009_bb0050
  article-title: Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2011.06.001
– volume: 100
  start-page: 228
  year: 2018
  ident: 10.1016/j.bbagen.2019.06.009_bb0085
  article-title: Highly sensitive surface plasmon resonance biosensor for the detection of HIV-related DNA based on dynamic and structural DNA nanodevices
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2017.08.042
– ident: 10.1016/j.bbagen.2019.06.009_bb0110
– volume: 37
  start-page: 715
  year: 2005
  ident: 10.1016/j.bbagen.2019.06.009_bb0040
  article-title: AC133/CD133/Prominin-1
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2004.08.010
– volume: 94
  start-page: 832
  year: 1999
  ident: 10.1016/j.bbagen.2019.06.009_bb0045
  article-title: AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors
  publication-title: Blood
  doi: 10.1182/blood.V94.2.832
– volume: 175
  start-page: 177
  year: 2011
  ident: 10.1016/j.bbagen.2019.06.009_bb0115
  article-title: SPR imaging biosensor for the 20S proteasome: sensor development and application to measurement of proteasomes in human blood plasma
  publication-title: Microchim. Acta
  doi: 10.1007/s00604-011-0656-6
– volume: 288
  start-page: 62
  year: 2018
  ident: 10.1016/j.bbagen.2019.06.009_bb0010
  article-title: Cancer stem cells-emanated therapy resistance: implications for liposomal drug delivery systems
  publication-title: J. Control Release
  doi: 10.1016/j.jconrel.2018.08.043
– volume: 26
  start-page: 4162
  year: 2011
  ident: 10.1016/j.bbagen.2019.06.009_bb0130
  article-title: Biosensor for direct cell detection, quantification and analysis
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2011.04.016
– volume: 90
  start-page: 5002
  year: 1997
  ident: 10.1016/j.bbagen.2019.06.009_bb0030
  article-title: AC133, a novel marker for human hematopoietic stem and progenitor cells
  publication-title: Blood
  doi: 10.1182/blood.V90.12.5002
– volume: 192
  start-page: 118
  year: 2018
  ident: 10.1016/j.bbagen.2019.06.009_bb0060
  article-title: Ultra-sensitive detection by metal nanoparticles-mediated enhanced SPR biosensors
  publication-title: Talanta
  doi: 10.1016/j.talanta.2018.09.023
– volume: 1862
  start-page: 1276
  year: 2018
  ident: 10.1016/j.bbagen.2019.06.009_bb0065
  article-title: Surface Plasmon resonance kinetic analysis of the interaction between G-quadruplex nucleic acids and an anti-G-quadruplex monoclonal antibody
  publication-title: Biochimica et Biophysica Acta (BBA)-General Subjects
  doi: 10.1016/j.bbagen.2018.03.002
– volume: 24
  start-page: 4
  year: 2011
  ident: 10.1016/j.bbagen.2019.06.009_bb0145
  article-title: Application of SPR biosensors in the detection of acute myeloid leukemia-associated antigen CD33
  publication-title: Chinese J. Sensors and Actuators
– volume: 8
  start-page: 102
  year: 2018
  ident: 10.1016/j.bbagen.2019.06.009_bb0125
  article-title: Trends in SPR cytometry: advances in label-free detection of cell parameters
  publication-title: Biosensors
  doi: 10.3390/bios8040102
– volume: 101
  start-page: 188
  year: 2018
  ident: 10.1016/j.bbagen.2019.06.009_bb0170
  article-title: Label-free biosensors in the field of stem cell biology
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2017.10.028
– volume: 15
  start-page: 494
  year: 2005
  ident: 10.1016/j.bbagen.2019.06.009_bb0005
  article-title: Cancer stem cells: lessons from leukemia
  publication-title: Trends Cell Biol.
  doi: 10.1016/j.tcb.2005.07.004
– start-page: 171
  year: 2002
  ident: 10.1016/j.bbagen.2019.06.009_bb0195
– volume: 3
  start-page: 730
  year: 1997
  ident: 10.1016/j.bbagen.2019.06.009_bb0025
  article-title: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
  publication-title: Nat. Med.
  doi: 10.1038/nm0797-730
– volume: 7
  start-page: 189
  year: 2017
  ident: 10.1016/j.bbagen.2019.06.009_bb0165
  article-title: Immuno-biosensor for detection of CD20-positive cells using surface Plasmon resonance
  publication-title: Adv. Pharm. Bull.
  doi: 10.15171/apb.2017.023
– volume: 140
  start-page: 989
  year: 2017
  ident: 10.1016/j.bbagen.2019.06.009_bb0080
  article-title: Modeling of a highly sensitive MoS2-graphene hybrid based fiber optic SPR biosensor for sensing DNA hybridization
  publication-title: Optik-International Journal for Light and Electron Optics
  doi: 10.1016/j.ijleo.2017.05.001
– volume: 14
  start-page: 4948
  year: 2014
  ident: 10.1016/j.bbagen.2019.06.009_bb0100
  article-title: Surface plasmon resonance for cell-based clinical diagnosis
  publication-title: Sensors
  doi: 10.3390/s140304948
– volume: 78
  start-page: 111
  year: 2016
  ident: 10.1016/j.bbagen.2019.06.009_bb0090
  article-title: Simultaneous differentiation and quantification of ricin and agglutinin by an antibody-sandwich surface plasmon resonance sensor
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2015.11.020
– volume: 86
  start-page: 8857
  year: 2014
  ident: 10.1016/j.bbagen.2019.06.009_bb0120
  article-title: Label-free quantitative detection of tumor-derived exosomes through surface plasmon resonance imaging
  publication-title: Anal. Chem.
  doi: 10.1021/ac5023056
– volume: 206
  start-page: 87
  year: 1997
  ident: 10.1016/j.bbagen.2019.06.009_bb0175
  article-title: Detection of blood group antigens utilising immobilised antibodies and surface plasmon resonance
  publication-title: J. Immunol. Methods
  doi: 10.1016/S0022-1759(97)00092-6
– volume: 63
  start-page: 1633
  year: 2017
  ident: 10.1016/j.bbagen.2019.06.009_bb0185
  article-title: Surface plasmon resonance is an analytically sensitive method for antigen profiling of extracellular vesicles
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2016.271049
– volume: 9
  start-page: 1097
  year: 2014
  ident: 10.1016/j.bbagen.2019.06.009_bb0055
  article-title: A reusable localized surface plasmon resonance biosensor for quantitative detection of serum squamous cell carcinoma antigen in cervical cancer patients based on silver nanoparticles array
  publication-title: Int. J. Nanomedicine
– volume: 158
  start-page: 376
  year: 2012
  ident: 10.1016/j.bbagen.2019.06.009_bb0190
  article-title: Acquired immunodeficiency syndrome and human immunodeficiency virus infection
  publication-title: Medical Secrets
  doi: 10.1016/B978-0-323-06398-2.00014-X
SSID ssj0000595
Score 2.4280531
Snippet Here, we reported the development of a label-free and real-time surface plasmon resonance (SPR) based biosensor for cancer stem cells (CSCs) detection using...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1575
SubjectTerms AC133 Antigen - analysis
Acute myeloid leukemia
Adult
antibodies
biomarkers
biosensors
bone marrow
Cancer stem cells
CD133
Female
Flow cytometry
gold
Humans
Leukemia, Myeloid, Acute - immunology
Leukemia, Myeloid, Acute - pathology
Male
myeloid leukemia
Neoplastic Stem Cells - cytology
Neoplastic Stem Cells - immunology
patients
SPR
stem cells
Surface Plasmon Resonance
Title Detection of CD133-marked cancer stem cells by surface plasmon resonance: Its application in leukemia patients
URI https://dx.doi.org/10.1016/j.bbagen.2019.06.009
https://www.ncbi.nlm.nih.gov/pubmed/31228554
https://www.proquest.com/docview/2245641594
https://www.proquest.com/docview/2286859604
Volume 1863
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRQguCMpr21IZiatZEjsP91ZtqbYgeoFKvVmOPZaWluxqkz30wm_vTB6lSEAlTnk5iuUZ258zn78BeJekSDjeG5n4GCX1xFyWfBax8lWCMVRdxPTLWT4_158usostmI17YZhWOYz9_ZjejdbDnenQmtPVYjH9ykE9ghMMQWhOK3nDr9YFe_n7n79oHgQfsj6SoCWXHrfPdRyvqqJOyyqoielUPJmW-Ofp6W_ws5uGTp7CkwE_iqO-is9gC-sdeNhnlLzegUezMYHbc6iPse2IVrVYRjE7pnWi_MFsnCA823otWMRZ8K_7RlTXotmso_MoVgSoyTkFLcSXLMeBh-K0bcSdULdY1OIKN5f0KScGZdbmBZyffPw2m8shvYL0ymStdIQ24geXquhUppGAlA_RaOeiyTE10eVF6mKOHKtj2XilKxdodYG5L1xZOvUStutlja9BaFQlrWgVHQsdfFa6LOigVdBFDAaTCaixVa0ftMc5BcaVHUlm321vC8u2sB3XzkxA3r616rU37ilfjAazv_mQpenhnjffjva1ZCRueFfjctPYlAPDBHKM_leZMi8zVrmZwKveOW7rqxJ6SpBt97_rtgeP-aonEO7Ddrve4BsCQm110Hn6ATw4Ov08P7sBUo8H2g
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RUEUvVaGv7QNcqVd3m9hJ7N6qBbRQ4FKQuFmOH9K2NLvaZA9c-O3M5EGL1BaJU6LYUSyPH99kPn8D8DFJA-J4p3niYuQ4E3Ou6C6G0pVJiL5sI6Ynp_n0XB5dZBdrMBnOwhCtsl_7uzW9Xa37J-O-N8eL2Wz8nYJ6CCcIguCeptQj2JA4fSmNwafr3zwPxA9ZF0qQnKoP5-dakldZ4qwlGdREtzKexEv8-_70L_zZ7kMHz-BpDyDZ166NW7AWqm143KWUvNqGzcmQwe05VHuhaZlWFZtHNtlDR5H_IjqOZ46MvWSk4szo333NyitWr5bRusAWiKhxdDL0xOekxxG-sMOmZn_EutmsYpdh9RM_ZVkvzVq_gPOD_bPJlPf5FbgTOmu4RbgRP9tURCsyGRBJOR-1tDbqPKQ62rxIbcwDBetIN17I0np0L0LuCquUFS9hvZpX4TUwGYRCl1bgtZDeZcpmXnopvCyi1yEZgRh61bhefJxyYFyagWX2w3S2MGQL05Lt9Aj47VuLTnzjnvrFYDBzZxAZ3B_uefPDYF-DRqKOt1WYr2qTUmQYUY6W_6ujcpWRzM0IXnWD47a9IsFSxGxvHty2Xdicnp0cm-PD029v4QmVdGzCd7DeLFfhPaKiptxpR_0NQegJaA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detection+of+CD133-marked+cancer+stem+cells+by+surface+plasmon+resonance%3A+Its+application+in+leukemia+patients&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Fathi%2C+Farzaneh&rft.au=Rahbarghazi%2C+Reza&rft.au=Movassaghpour%2C+Ali+Akbar&rft.au=Rashidi%2C+Mohammad-Reza&rft.date=2019-10-01&rft.issn=0304-4165&rft.volume=1863&rft.issue=10&rft.spage=1575&rft.epage=1582&rft_id=info:doi/10.1016%2Fj.bbagen.2019.06.009&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bbagen_2019_06_009
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon